Financings Of The Fortnight: IPOs Make A Return In Talecris And Omeros Deals
This article was originally published in The Pink Sheet Daily
Executive Summary
Money continued to flow to big and small biotechs, including nearly a dozen PIPEs or registered direct offerings.